Home LiteratureArticle Details
PMID: 11162087 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Genetic interaction between yeast Saccharomyces cerevisiae release factors and the decoding region of 18 S rRNA.

Journal of molecular biology ·Vol. 305 ·No. 4 ·2001-01-26 ·Pages 715-27

Velichutina IV, Hong JY, Mesecar AD, Chernoff YO, Liebman SW

Abstract

Functional and structural similarities between tRNA and eukaryotic class 1 release factors (eRF1) described previously, provide evidence for the molecular mimicry concept. This concept is supported here by the demonstration of a genetic interaction between eRF1 and the decoding region of the ribosomal RNA, the site of tRNA-mRNA interaction. We show that the conditional lethality caused by a mutation in domain 1 of yeast eRF1 (P86A), that mimics the tRNA anticodon stem-loop, is rescued by compensatory mutations A1491G (rdn15) and U1495C (hyg1) in helix 44 of the decoding region and by U912C (rdn4) and G886A (rdn8) mutations in helix 27 of the 18 S rRNA. The rdn15 mutation creates a C1409-G1491 base-pair in yeast rRNA that is analogous to that in prokaryotic rRNA known to be important for high-affinity paromomycin binding to the ribosome. Indeed, rdn15 makes yeast cells extremely sensitive to paromomycin, indicating that the natural high resistance of the yeast ribosome to paromomycin is, in large part, due to the absence of the 1409-1491 base-pair. The rdn15 and hyg1 mutations also partially compensate for inactivation of the eukaryotic release factor 3 (eRF3) resulting from the formation of the [PSI+] prion, a self-reproducible termination-deficient conformation of eRF3. However, rdn15, but not hyg1, rescues the conditional cell lethality caused by a GTPase domain mutation (R419G) in eRF3. Other antisuppressor rRNA mutations, rdn2(G517A), rdn1T(C1054T) and rdn12A(C526A), strongly inhibit [PSI+]-mediated stop codon read-through but do not cure cells of the [PSI+] prion. Interestingly, cells bearing hyg1 seem to enable [PSI+] strains to accumulate larger Sup35p aggregates upon Sup35p overproduction, suggesting a lower toxicity of overproduced Sup35p when the termination defect, caused by [PSI+], is partly relieved.

MeSH Terms
Anti-Bacterial Agents/metabolism,pharmacology Anticodon/chemistry,genetics Base Pairing Base Sequence Codon, Terminator/genetics Drug Resistance, Microbial Frameshift Mutation/genetics Fungal Proteins/chemistry,genetics,metabolism Genes, Fungal/genetics Genes, Lethal/genetics Paromomycin/metabolism,pharmacology Peptide Termination Factors/biosynthesis,chemistry,genetics,metabolism Protein Biosynthesis/drug effects RNA, Ribosomal, 18S/chemistry,genetics,metabolism Ribosomes/metabolism Saccharomyces cerevisiae/cytology,drug effects,genetics,metabolism Suppression, Genetic/genetics
Chemicals
Anti-Bacterial Agents Anticodon Codon, Terminator Fungal Proteins Peptide Termination Factors RNA, Ribosomal, 18S peptide-chain-release factor 3 Paromomycin
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Velichutina I V
Laboratory for Molecular Biology, Department of Biological Sciences, University of Illinois at Chicago, Chicago, IL, 60607, USA
Hong J Y
Mesecar A D
Chernoff Y O
Liebman S W
Article Info
Journal
Journal of molecular biology
Abbr.
J Mol Biol
ISSN
0022-2836
Published
2001-01-26
Pages
715-27
Language
English
Region
England
NLM ID
2985088R
Subset
IM
Grants
NIGMS NIH HHS · GM51412 · United States
NIGMS NIH HHS · GM56350 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com